Eur Heart J Case Rep 2020 Dec 9;4(6):1-4. Epub 2020 Nov 9.
Division of Cardiology, Rush University Medical Center, 1717 W Congress parkway, Suite 313, 3-Kellogg, Chicago, IL, USA.
Background: Transcatheter mitral valve-in-valve implantation (MVIV) has emerged as a viable treatment option in patients at high risk for surgery. Occasionally, despite appropriate puncture location and adequate dilation, difficulty is encountered in advancing the transcatheter heart valve across interatrial septum.
Case Summary: We describe a case of a 79-year-old woman with severe chronic obstructive pulmonary disease (COPD), prior surgical bioprosthetic aortic and mitral valve replacement implanted in 2007, atrial fibrillation, and Group II pulmonary hypertension who presented with progressively worsening heart failure symptoms secondary to severe bioprosthetic mitral valve stenosis and moderate-severe mitral regurgitation. Read More